CLF News 18.08 05/07/2014 04:34:48 Cliffs Natural Resources Inc

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cliffs Natural Resources Inc (CLF) 18.08 $CLF

Stock Price Movements, Earnings Releases, and Upcoming Shareholder Meeting - Analyst Notes on Occidental Petroleum, KMI, Phillips 66, Cliffs and MPC
PR Newswire - Wed Apr 30, 1:57PM CDT
Today, Analysts Review released its analysts' notes regarding Occidental Petroleum Corporation (NYSE: OXY), Kinder Morgan Inc. (NYSE: KMI), Phillips 66 (NYSE: PSX), Cliffs Natural Resources Inc. (NYSE: CLF) and Marathon Petroleum Corp. (NYSE: MPC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1865-100free.

Harsh Winter Contributes to Cliffs Natural Resources' Problems
Vladimir Zernov, The Motley Fool - Motley Fool - Tue Apr 29, 1:50PM CDT
Sometimes problems multiply at the most inappropriate times. This happened to Cliffs Natural Resources in the first quarter. The company, which suffers from low iron ore and met coal prices, took a hit from the harsh winter weather. As a result,...

Watch for Shares of Cliffs Natural Resources (CLF) to Approach Support at $16.93
Comtex SmarTrend(R) - Mon Apr 28, 9:04AM CDT
Shares of Cliffs Natural Resources (NYSE:CLF) opened today below their pivot of $17.99 and have already reached the first level of support at $17.47. Analysts will be watching for a cross of the next downside pivot targets of $16.93 and $15.87.

Will This EPS Change Hurt Cliffs Natural Resources (CLF) Stock Today?
at The Street - Mon Apr 28, 8:58AM CDT
Cliffs Natural Resources (CLF) has had its earnings estimates reduced, BMO Capital Markets said Monday. The firm reiterated a "market perform" rating and $22 price target.

Technical Updates on Active Stocks -- Research on Cliffs Natural Resources, Huntington Bancshares, Twenty-First Century Fox, and Barrick Gold
PR Newswire - Mon Apr 28, 8:30AM CDT
The trading session on Friday, April 25, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,361.46, down 0.85% and the NASDAQ Composite closed at 4,075.56, down 1.75%. The S&P 500 ended the day 0.81% lower at 1,863.40. The losses were broad based as eight out of ten sectors finished on a lower note. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Cliffs Natural Resources Inc. (NYSE: CLF), Huntington Bancshares Inc. (NASDAQ: HBAN), Twenty-First Century Fox Inc. (NASDAQ: FOXA) and Barrick Gold Corp. (NYSE: ABX). Free technical research on CLF, HBAN, FOXA and ABX can be downloaded upon signing up at:

Cliffs Natural Resources Set to Possibly Rebound After Yesterday's Selloff of 4.05%
Comtex SmarTrend(R) - Fri Apr 25, 4:58PM CDT
Cliffs Natural Resources (NYSE:CLF) traded in a range yesterday that spanned from a low of $17.46 to a high of $18.52. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $18.06 on volume of 11.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Casablanca Capital Statement Regarding Scheduling of Cliffs Natural Resources Annual Meeting
Business Wire - Fri Apr 25, 1:06PM CDT
Casablanca Capital LP, ("Casablanca" the beneficial owner of approximately 5.2% of Cliffs Natural Resources Inc. (NYSE:CLF), today commented on Cliffs Natural Resources' announcement that it will hold its annual meeting of shareholders on July 29, 2014, with shareholders of record as of the close of business on June 2, 2014 entitled to vote at the meeting.

Wider-than-Expected Loss at Cliffs Natural - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 25, 11:10AM CDT
Cliffs Natural Resources Inc. (CLF) reported first-quarter 2014 net loss of $83 million, or 54 cents per share compared with a net income of $97 million or 66 cents per share in the year-ago quarter.

Cliffs Natural Resources Inc. Announces 2014 Annual Meeting of Shareholders
Thomson Reuters ONE - Fri Apr 25, 10:04AM CDT
CLEVELAND - April 25, 2014 - Cliffs Natural Resources Inc. (NYSE: CLF) (Paris: CLF) today announced that its Board of Directors has scheduled its annual meeting of shareholders to be held on July 29, 2014. Shareholders of record as of the close of business on June 2, 2014 will be entitled to vote at the annual meeting.

Rough Winter Wrecks Cliffs Natural Resources Inc's First-Quarter Results
Matt DiLallo, The Motley Fool - Motley Fool - Thu Apr 24, 4:14PM CDT
Cliffs Natural Resources announced its first-quarter results after the closing bell today. The company reported revenue of $940 million and a net loss of $83 million or $0.54 per share. Revenue was down 18% over the previous year as a...

Cliffs Natural Resources Inc. Reports First-Quarter 2014 Results and Maintains Full-Year 2014 Volume and Cost Outlook
Thomson Reuters ONE - Thu Apr 24, 3:31PM CDT
- Company Reports 2014 First-Quarter Consolidated Revenues of $940 Million

Watch Out For Too Many Stock Splits
at Investor's Business Daily - Thu Apr 24, 2:47PM CDT
Having a little ice cream every once in a while may be fine. But too much of a good thing isn't so good. In the stock market, it's OK for a company to split its stock every few years. But too many splits can hurt a stock's performance and mark a...

Watch for Shares of Cliffs Natural Resources (CLF) to Approach Resistance at $18.72
Comtex SmarTrend(R) - Thu Apr 24, 1:01PM CDT
Shares of Cliffs Natural Resources (NYSE:CLF) opened today above their pivot of $18.28 and have already reached the first level of resistance at $18.51. Should the shares continue to rise, the resistance pivots of $18.72 and $19.16 will be of interest.

AK Steel Is Well Positioned Despite Dramatic First Quarter
Vladimir Zernov, The Motley Fool - Motley Fool - Wed Apr 23, 2:18PM CDT
When a company's CEO starts the quarterly earnings call with the words, " Thank goodness it’s behind us " one would expect catastrophic results from this company. Interestingly, this was not the case for AK Steel , whose CEO James Wainscott said...

Cliffs Natural Resources, Inc. Earnings: Is the Bottom Finally In?
Dan Caplinger, The Motley Fool - Motley Fool - Wed Apr 23, 10:15AM CDT
On Thursday, Cliffs Natural Resources will release its quarterly report, and long-struggling shareholders aren't expecting any relief from the woes that have depressed earnings and revenue. Yet even as weakness in iron ore prices has held back ...

Investors Think This Stock Is About to Fall Off a Cliff
Matt DiLallo, The Motley Fool - Motley Fool - Tue Apr 22, 12:05PM CDT
Investors have shorted more than 50 million shares of Cliffs Natural Resources . That's about one third of the total publicly traded float. Neither insiders nor institutions are bullish on the stock either as these two typically large holders own...

Cliffs Natural Resources Falls 1.02% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 21, 4:57PM CDT
Cliffs Natural Resources (NYSE:CLF) traded in a range yesterday that spanned from a low of $18.03 to a high of $18.65. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $18.47 on volume of 6.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Cliffs Natural Resources Inc. Issues Statement
Thomson Reuters ONE - Mon Apr 21, 3:06PM CDT
Remains Ready to Engage with Casablanca to Reach Resolution in Best Interests of All Cliffs Shareholders
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading